Tissue Regenix has appointed Steven Couldwell as a non-executive director of the Group
Steven has a proven international track record in driving revenues and profit growth in both the medical device and CRO industries. With over 14 years of senior management experience, Steven is currently Vice President and Head of Global Biosurgery at Sanofi, which has revenues of approximately $750m.
Share
Download our apps
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.